Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals.

Uzzan M, Tokuyama M, Rosenstein AK, Tomescu C, SahBandar IN, Ko HM, Leyre L, Chokola A, Kaplan-Lewis E, Rodriguez G, Seki A, Corley MJ, Aberg J, La Porte A, Park EY, Ueno H, Oikonomou I, Doron I, Iliev ID, Chen BK, Lui J, Schacker TW, Furtado GC, Lira SA, Colombel JF, Horowitz A, Lim JK, Chomont N, Rahman AH, Montaner LJ, Ndhlovu LC, Mehandru S.

Sci Transl Med. 2018 Oct 3;10(461). pii: eaau4711. doi: 10.1126/scitranslmed.aau4711.

2.

The current state of the art for biological therapies and new small molecules in inflammatory bowel disease.

Paramsothy S, Rosenstein AK, Mehandru S, Colombel JF.

Mucosal Immunol. 2018 Nov;11(6):1558-1570. doi: 10.1038/s41385-018-0050-3. Epub 2018 Jun 15. Review.

3.

Efficient long-term depletion of CD20+ B cells by rituximab does not affect gut-resident plasma cells.

Uzzan M, Ko HM, Rosenstein AK, Pourmand K, Colombel JF, Mehandru S.

Ann N Y Acad Sci. 2018 Mar;1415(1):5-10. doi: 10.1111/nyas.13577. Epub 2017 Dec 31.

4.

Alopecia areata universalis complicating daclizumab therapy for uveitis.

Rosenstein AK, Machler BC, Rosenstein ED.

Cutis. 2014 May;93(5):E13-6.

PMID:
24897146

Supplemental Content

Loading ...
Support Center